Download PDF
Pneumologie 2020; 74(12): 842-846
DOI: 10.1055/a-1238-5193
Schritt für Schritt

High-Flow-Sauerstofftherapie – Schritt für Schritt

C. Wachs
,
J. Grensemann
,
S. Kluge
› Further Information
Also available at
   Permissions and Reprints

In den letzten Jahren hat sich die High-Flow-Sauerstofftherapie (HFNC) auf den meisten Intensivstationen als Oxygenierungsmethode bei respiratorisch stark eingeschränkten Patienten etabliert und bewährt. Vorteile dieses Verfahrens, das insbesondere bei Patienten mit einer Hypoxämie eingesetzt wird, sind die einfache Applikation und die gute Toleranz durch den Patienten.

Publication History

Article published online:
08 December 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Simon M, Grensemann J, Kluge S. High-Flow-Sauerstofftherapie in der Intensivmedizin. Journal Club AINS 2018; 7: 106-116
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Sztrymf B, Messika J, Bertrand F. et al. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med 2011; 37: 1780-1786
    CrossrefPubMedGoogle Scholar
  • 3 Luo JC, Lu MS, Zhao ZH. et al. Positive end-expiratory pressure effect of 3 high-flow nasal cannula devices. Respir Care 2017; 62: 888-895
    CrossrefPubMedGoogle Scholar
  • 4 Besnier E, Hobeika S, NSeir S. et al. High-flow nasal cannula therapy: clinical practice in intensive care units. Ann Intensive Care 2019; 9: 98
    CrossrefPubMedGoogle Scholar
  • 5 Rochwerg B, Granton D, Wang DX. et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019; 45: 563-572
    CrossrefPubMedGoogle Scholar
  • 6 Grensemann J, Fuhrmann V, Kluge S. Oxygen treatment in intensive care and emergency medicine. Dtsch Arztebl Int 2018; 115: 455
    Google Scholar
  • 7 Chu DK, Kim LH, Young PJ. et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 2018; 391: 1693-1705
    CrossrefPubMedGoogle Scholar
  • 8 Kotoda M. et al Assessment of the potential for pathogen dispersal during high-flow nasal therapy. J Hosp Infect 2019
    Google Scholar
  • 9 Hui DS. et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019; 53: 1802339
    CrossrefPubMedGoogle Scholar
  • 10 Hui DS. et al. Exhaled air and aerosolized droplet dispersion during application of a jet nebulizer. Chest 2019; 135 (03): 648-654
    PubMedGoogle Scholar
  • 11 Leonard S. et al Preliminary Findings of Control of Dispersion of Aerosols and Droplets during High Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask: Implications for High Flow Nasal Cannula. Chest 2020
    Google Scholar
  • 12 Kluge S. et al. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19. Med Klin Intensivmed Notfmed 2020; 115 (3): 175-177
    CrossrefPubMedGoogle Scholar